GC68807
Briakinumab
Briakinumab (ABT-874) is a fully human monoclonal antibody that targets and neutralizes IL-12/23p40· Briakinumab specifically targets and neutralizes both IL-12 and IL-23· It is being studied for its potential use in rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis
ChemicalCAS339308-60-0
- CAS number
- 339308-60-0
- Molecular weight
- —
- Formula
- —
- Catalogue number
- GC68807
- Brand
- GLPBIO
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il